Scott R Curry
Overview
Explore the profile of Scott R Curry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curry S, Hecker M, OHagan J, Kutty P, Ng-Wong Y, Cadnum J, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Sep;
4(1):e144.
PMID: 39346661
Background: The incubation period for infection (CDI) is generally considered to be less than 1 week, but some recent studies suggest that prolonged carriage prior to disease onset may be...
2.
Colbrunn D, Jacks C, Curry S, Gebregziabher M, Meissner E
AIDS
. 2024 Mar;
38(8):1181-1185.
PMID: 38489581
Objective: The aim of this study was to examine outcomes of follow-up for persons with discordant fourth-generation HIV screening test results. Design: A retrospective chart review. Methods: We analyzed the...
3.
Overbeck V, Taylor B, Turcinovic J, Qiu X, Schaeffer B, Seitz S, et al.
Heliyon
. 2024 Jan;
10(1):e23699.
PMID: 38223743
Background: Immunocompromised patients receiving B-cell-depleting therapies are at increased risk of persistent SARS-CoV-2 infection, with many experiencing fatal outcomes. We report a successful outcome in a patient with rheumatoid arthritis...
4.
Hamidi B, Steed L, Curry S, Salgado C, Alekseyenko A
Res Sq
. 2023 Sep;
PMID: 37693618
Background: Hospital-acquired infections present a major concern for healthcare systems in the U.S. and worldwide. Drug-resistant infections result in increased costs and prolonged hospital stays. Methicillin-resistant (MRSA) and vancomycin-resistant (VRE)...
5.
Curry S, Hecker M, OHagan J, Kutty P, Alhmidi H, Ng-Wong Y, et al.
Clin Infect Dis
. 2023 Mar;
77(1):77-83.
PMID: 36905149
Background: Limited information is available on the natural history of Clostridioides difficile colonization and infection in patients with new acquisition of C. difficile in healthcare settings. Methods: In 3 hospitals...
6.
Xu G, Emanuel A, Nadig S, Mehrotra S, Caddell B, Curry S, et al.
Clin Chem
. 2020 Sep;
66(12):1531-1537.
PMID: 32894753
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody testing is an important tool in assessment of pandemic progress, contact tracing, and identification of recovered coronavirus disease 2019 (COVID-19) patients....
7.
8.
Puri S, Hughes H, McCrackin M, Williford R, Gebregziabher M, Salgado C, et al.
Infect Control Hosp Epidemiol
. 2020 Jan;
41(4):467-468.
PMID: 31973777
Healthcare-facility-onset C.difficile LabID events are defined as positive stool samples collected >3 days after hospitalization. Using a definition of >72 hours, we found that 84 of 1013 cases (8.3%) identified...
9.
Curry S
J Clin Microbiol
. 2019 Mar;
57(5).
PMID: 30867236
Since 2001, numerous descriptive ecological studies of infections (CDI) have identified a single lineage (BI/NAP1/027) associated with the epidemics of CDI, increased severity of CDI, and increased likelihood of incident...
10.
Brown C, Manis M, Bohm N, Curry S
Ann Pharmacother
. 2018 Nov;
53(4):396-401.
PMID: 30450942
Objective: To summarize and critically appraise the evidence regarding oral vancomycin prophylaxis (OVP) to prevent recurrent Clostridium difficile infections (RCDIs), identify potential consequences of this emerging practice, and highlight future...